Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis;Rol patogénico del gen supresor de tumores PTEN en cáncer ovárico asociado a endometriosis

Revista Medica de Chile

Volumn 134, Issue 3, 2006, Pages 271-278

  Castiblanco G, Adriana ^a,d   Pires N, Yumay ^a,b   Wistuba O, Ignacio ^a,c   Riquelme S, Erick ^a   Andrade M, Leonardo ^a   Corvalán R, Alejandro ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Endometrial neoplasms; Endometriosis; Human; Ovarian neoplasms; PTEN protein

Indexed keywords

KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL TRANSFORMATION; DISEASE COURSE; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; GENETIC MARKER; GENETICS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; AGED; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ENDOMETRIOSIS; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LOSS OF HETEROZYGOSITY; MIDDLE AGED; OVARIAN NEOPLASMS; PTEN PHOSPHOHYDROLASE;

EID: 33646489761     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. KURMAN RE. Blaustein's Pathology of the Female Genitale Tract. Fourth Edition ed.
2. FUKUNAGA M, NOMURA K, ISHIKAWA E, USHIGOME S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30: 249-55.
3. BRINTON LA, GRIDLEY G, PERSSON I, BARON J, BERGQVIST A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572-9.
4. FEELEY KM, WELLS M. Precursor lesions of ovarian epithelial malignancy. Histopathology 2001; 38: 87-95.
5. LAGRENADE A, SILVERBERG SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19: 1080-4.
6. NISOLLE M, CASANAS-ROUX F, DONNEZ J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 1997; 68: 912-9.
7. NILBERT M, PEJOVIC T, MANDAHL N, IOSIF S, WILLEN H, MITELMAN F. Monoclonal origin of endometriotic cysts. Int J Gynecol Cancer 1995; 5: 61-3.
8. THOMAS EJ, CAMPBELL IG. Molecular genetic defects in endometriosis. Gynecol Obstet Invest 2000; 50 Suppl 1: 44-50.
9. YANO T, JIMBO H, YOSHIKAWA H, TSUTSUMI O, TAKETANI Y. Molecular analysis of clonality in ovarian endometrial cysts. Gynecol Obstet Invest 1999; 47 Suppl 1: 41-45; discussion 46.
10. JIANG X, MORLAND SJ, HITCHCOCK A, THOMAS EJ, CAMPBELL IG. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998; 58: 1707-12.
11. VOGELSTEIN B, KINZLER K. The Genetic Basis of Human Cancer. New York: McGraw-Hill, 2001.
12. RISINGER JI, HAYES AK, BERCHUCK A, BARRETT JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57: 4736-8.
13. SATO N, TSUNODA H, NISHIDA M, MORISHITA Y, TAKIMOTO Y, KUBO T ET AL. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000; 60: 7052-6.
14. OBATA K, HOSHIAI H. Common genetic changes between endometriosis and ovarian cancer. Gynecol Obstet Invest 2000; 50 Suppl 1: 39-43.
15. JAFFE ES, HARRIS NL, STEIN H, VARDIMAN JW. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2001.
16. KANAMORI Y, KIGAWA J, ITAMOCHI H, SHIMADA M, TAKAHASHI M, KAMAZAWA S ET AL. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 2001; 7: 892-5.
17. SALVESEN HB, MACDONALD N, RYAN A, JACOBS IJ, LYNCH ED, AKSLEN LA ET AL. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 2001; 91: 22-6.
18. FU Y, CAMPBELL EJ, SHEPHERD TG, NACHTIGAL MW. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells. Mol Cancer Res 2003; 1: 569-76.
19. NEZHAT F, COHEN C, RAHAMAN J, GRETZ H, COLE P, KALIR T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 2002; 94: 2935-40.
20. NEZHAT FR, KALIR T. Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts. Fertil Steril 2002; 78: 820-4.
21. LIU WG, JAME CD, FREDERIK L, ALDERETE BE, JENKINS RB. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 1997; 57: 5254-7.
22. CAIRS P, OKAMI K, HALACHMI N, ESTELLER M, HERMAN JC, ISAACS WB ET AL. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997; 57: 4997-5000.
23. LIAW D, MARSH DJ, LI J, DAHIA PLM, WANG SI, ZHENG ZM ET AL. Germline mutations of the PTEN gene in Cowden disease, and inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16: 64-7.
24. ORBO A, NILSEN M, ARNES M, PETTERSEN I, LEARSEN K. Loss of expresión of MLH1-MSH2, MSH6 and PTEN Related to Endometrial Cancer in 68 Patients with Endometrial Hyperplasia. Int J Gynecol Pathol 2003; 22: 141-8.
25. SALVESEN HB, STEFANSSON I, KALVENES MB, DAS S, AKSLEN LA. Loss of PTEN expression is associated with metastasic disease in patients with endometrial carcinoma. Cancer 2002; 94: 2185-91.